Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 34% ± 18% | |
lung | 12 studies | 26% ± 8% | |
kidney | 6 studies | 20% ± 4% | |
pancreas | 4 studies | 47% ± 28% | |
intestine | 4 studies | 21% ± 7% | |
peripheral blood | 4 studies | 24% ± 6% | |
eye | 4 studies | 24% ± 7% | |
uterus | 4 studies | 29% ± 12% | |
placenta | 3 studies | 31% ± 6% | |
adipose | 3 studies | 19% ± 4% | |
esophagus | 3 studies | 25% ± 13% | |
liver | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6167.30 | 1444 / 1445 | 100% | 91.74 | 183 / 183 |
breast | 100% | 7254.90 | 459 / 459 | 100% | 110.00 | 1116 / 1118 |
ovary | 100% | 6370.90 | 180 / 180 | 100% | 59.79 | 429 / 430 |
liver | 100% | 6522.82 | 226 / 226 | 100% | 112.76 | 405 / 406 |
lung | 100% | 7731.72 | 577 / 578 | 100% | 90.53 | 1152 / 1155 |
brain | 99% | 8838.95 | 2626 / 2642 | 100% | 116.02 | 705 / 705 |
thymus | 100% | 6992.28 | 653 / 653 | 99% | 97.14 | 601 / 605 |
skin | 100% | 10120.38 | 1809 / 1809 | 99% | 137.01 | 468 / 472 |
uterus | 100% | 6058.20 | 170 / 170 | 99% | 79.54 | 455 / 459 |
kidney | 100% | 6576.20 | 89 / 89 | 99% | 102.60 | 893 / 901 |
prostate | 100% | 5652.47 | 244 / 245 | 99% | 111.24 | 499 / 502 |
stomach | 100% | 4790.16 | 359 / 359 | 99% | 63.30 | 283 / 286 |
pancreas | 99% | 3822.33 | 326 / 328 | 99% | 65.94 | 177 / 178 |
intestine | 100% | 4906.10 | 966 / 966 | 98% | 58.39 | 517 / 527 |
adrenal gland | 100% | 8254.02 | 258 / 258 | 96% | 59.74 | 221 / 230 |
bladder | 100% | 5046.86 | 21 / 21 | 93% | 58.40 | 468 / 504 |
adipose | 100% | 7186.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 8386.30 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4903.39 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 85.04 | 45 / 45 |
blood vessel | 100% | 5985.65 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 11708.58 | 922 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 61.75 | 77 / 80 |
lymph node | 0% | 0 | 0 / 0 | 93% | 39.07 | 27 / 29 |
heart | 93% | 3670.37 | 798 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0017038 | Biological process | protein import |
GO_0046716 | Biological process | muscle cell cellular homeostasis |
GO_0007042 | Biological process | lysosomal lumen acidification |
GO_0009267 | Biological process | cellular response to starvation |
GO_0006605 | Biological process | protein targeting |
GO_0031647 | Biological process | regulation of protein stability |
GO_0061740 | Biological process | protein targeting to lysosome involved in chaperone-mediated autophagy |
GO_0061684 | Biological process | chaperone-mediated autophagy |
GO_0050821 | Biological process | protein stabilization |
GO_1905146 | Biological process | lysosomal protein catabolic process |
GO_0097352 | Biological process | autophagosome maturation |
GO_0005615 | Cellular component | extracellular space |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0044754 | Cellular component | autolysosome |
GO_0031088 | Cellular component | platelet dense granule membrane |
GO_0005764 | Cellular component | lysosome |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0035577 | Cellular component | azurophil granule membrane |
GO_0098857 | Cellular component | membrane microdomain |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005770 | Cellular component | late endosome |
GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0019899 | Molecular function | enzyme binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0008200 | Molecular function | ion channel inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | LAMP2 |
Protein name | Lysosomal-associated membrane protein 2 Lysosomal associated membrane protein 2 Lysosome-associated membrane glycoprotein 2 (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b) |
Synonyms | |
Description | FUNCTION: Lysosomal membrane glycoprotein which plays an important role in lysosome biogenesis, lysosomal pH regulation and autophagy . Acts as an important regulator of lysosomal lumen pH regulation by acting as a direct inhibitor of the proton channel TMEM175, facilitating lysosomal acidification for optimal hydrolase activity . Plays an important role in chaperone-mediated autophagy, a process that mediates lysosomal degradation of proteins in response to various stresses and as part of the normal turnover of proteins with a long biological half-live . Functions by binding target proteins, such as GAPDH, NLRP3 and MLLT11, and targeting them for lysosomal degradation . In the chaperone-mediated autophagy, acts downstream of chaperones, such as HSPA8/HSC70, which recognize and bind substrate proteins and mediate their recruitment to lysosomes, where target proteins bind LAMP2 . Plays a role in lysosomal protein degradation in response to starvation (By similarity). Required for the fusion of autophagosomes with lysosomes during autophagy . Cells that lack LAMP2 express normal levels of VAMP8, but fail to accumulate STX17 on autophagosomes, which is the most likely explanation for the lack of fusion between autophagosomes and lysosomes . Required for normal degradation of the contents of autophagosomes . Required for efficient MHC class II-mediated presentation of exogenous antigens via its function in lysosomal protein degradation; antigenic peptides generated by proteases in the endosomal/lysosomal compartment are captured by nascent MHC II subunits . Is not required for efficient MHC class II-mediated presentation of endogenous antigens . .; FUNCTION: [Isoform LAMP-2C]: Modulates chaperone-mediated autophagy. Decreases presentation of endogenous antigens by MHCII. Does not play a role in the presentation of exogenous and membrane-derived antigens by MHCII. .; FUNCTION: (Microbial infection) Supports the FURIN-mediated cleavage of mumps virus fusion protein F by interacting with both FURIN and the unprocessed form but not the processed form of the viral protein F. . |
Accessions | ENST00000434600.6 [P13473-3] P13473 ENST00000706600.1 H0YCG2 ENST00000200639.9 [P13473-1] A0A9L9PXQ4 A0A1B1HY35 A0A1B1HY22 ENST00000371335.4 [P13473-2] ENST00000486593.5 |